Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/22/15 → 7/22/18 |
Funding
- inVentiv Health Clinical (Prot #42160443PAI3001 // Prot #42160443PAI3001)
- Janssen Research & Development, LLC (Prot #42160443PAI3001 // Prot #42160443PAI3001)
Prot #42160443PAI3001: Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Adjunctive Therapy in Subjects with Signs and Symptoms of Osteoarthritis of the Hip or Knee
- Schnitzer, Thomas J (PD/PI)
Project: Research project